Mylan is recalling two lots of levoleucovorin injection, a chemotherapy drug, because copper salts were found in the samples during a 12-month stability testing.
Pfizer’s Hospira plant is recalling three lots of a sodium bicarbonate injection after glass particles were discovered in some vials.
Neither company has received reports of adverse events related to the recall.
“Administration of a sterile injectable that has foreign particulates has the potential of severe health consequences,” Mylan said in the recall notice.
Both companies have notified their direct customers.
More articles on pharmacy:
Harvard gets $100M infusion for drug research from hedge fund
Purdue Pharma CEO: Bankruptcy is ‘an option’ amid lawsuits
Intermountain CEO Dr. Marc Harrison: How Civica Rx will disrupt the drug industry
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
